Stivarga and Genital erosion - a phase IV clinical study of FDA data

Summary:

Genital erosion is reported only by a few people who take Stivarga.

The phase IV clinical study analyzes which people take Stivarga and have Genital erosion. It is created by eHealthMe based on reports of 8,313 people who have side effects while taking Stivarga from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

8,313 people reported to have side effects when taking Stivarga.
Among them, 4 people (0.05%) have Genital erosion.


What is Stivarga?

Stivarga has active ingredients of regorafenib. eHealthMe is studying from 8,322 Stivarga users for its effectiveness, alternative drugs and more.

What is Genital erosion?

Genital erosion (ulcer on genital) is found to be associated with 251 drugs and 220 conditions by eHealthMe.

Number of Stivarga and Genital erosion reports submitted per year:

Could Stivarga cause Genital erosion?

Time on Stivarga when people have Genital erosion *:

  • < 1 month: 66.67 %
  • 1 - 6 months: 33.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Genital erosion when taking Stivarga *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Genital erosion when taking Stivarga *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 75 %

Common drugs people take besides Stivarga *:

  1. Oxycontin: 1 person, 25.00%
  2. Norvasc: 1 person, 25.00%
  3. Nexium: 1 person, 25.00%
  4. Blopress: 1 person, 25.00%

Common side effects people have besides Genital erosion *:

  1. Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 2 people, 50.00%
  2. Skin Disorder (skin disease): 1 person, 25.00%
  3. Peripheral Swelling: 1 person, 25.00%
  4. Hoarseness Or Changing Voice: 1 person, 25.00%
  5. Diarrhea: 1 person, 25.00%
  6. Colon Cancer: 1 person, 25.00%

Common conditions people have *:

  1. Colon Cancer: 3 people, 75.00%
  2. Hepatocellular Carcinoma (liver cancer): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Stivarga and have Genital erosion?

Check whether Genital erosion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Genital erosion and when was it recovered:

Expand to all the drugs that have ingredients of regorafenib:

Alternative drugs to, pros and cons of Stivarga:

Common Stivarga side effects:

Browse all side effects of Stivarga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Genital erosion treatments and more:

COVID vaccines that are related to Genital erosion:

All the drugs that are associated with Genital erosion:

All the conditions that are associated with Genital erosion:

How the study uses the data?

The study uses data from the FDA. It is based on regorafenib (the active ingredients of Stivarga) and Stivarga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: